Europe Transplant Market was valued at US$51.947 billion in 2021 and is projected to expand at a CAGR of 5.02% over the forecast period to reach US$73.193 billion by 2028.
Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continues to receive nourishment from the new and healthy environment. The prevalence of chronic diseases is one of the major factors driving the growth of the Europe transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the Europe transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and in the upcoming years.
This research study examines the Europe transplant market based on various segments: type, procedure, product, and countries. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model analyzes the emergency shutdown system industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.
The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the Europe transplant market. Moreover, the research study analyzes the overall regulatory framework of the emergency shutdown system sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.
Europe transplant market – Forecasts from 2023 to 2028 are a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.
The scope and coverage of the Europe transplant market report are as below:
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2021 | US$51.947 billion |
| Market Size Value in 2028 | US$73.193 billion |
| Growth Rate | CAGR of 5.02% from 2021 to 2028 |
| Base Year | 2021 |
| Forecast Period | 2023 – 2028 |
| Forecast Unit (Value) | USD Billion |
| Segments Covered | Type, Procedure, Product, and Country |
| Regions Covered | United Kingdom, Germany, France, Spain, Others |
| Companies Covered | Veloxis Pharmaceuticals A/S, Bridge to Life Ltd., Paragonix Technologies Inc., Novartis AG, XVIVO Perfusion, F. Hoffmann-La Roche AG |
| Customization Scope | Free report customization with purchase |
Different segments covered under the Europe transplant market report are as below: